Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Olema Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 76 | 1 | 97 | +22 |
| Shares | 36.7M | 25.5K | 38.4M | +1.71M (+4.7%) |
| Value | $1.01B | $701.0K | $359.5M | −$652.3M (−64.5%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (41)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (19)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| OrbiMed Advisors LLC | 807,792 | $22.3M |
| Foresite Capital Management IV, LLC | 342,030 | $9.43M |
| Sectoral Asset Management Inc | 338,381 | $9.33M |
| Great Point Partners LLC | 329,086 | $9.07M |
| Deerfield Management Company, L.P. (Series C) | 271,191 | $7.47M |
| Ameriprise Financial Inc | 210,926 | $5.82M |
| Acuta Capital Partners, LLC | 150,500 | $4.15M |
| Pictet Asset Management SA | 150,133 | $4.14M |
| Russell Investments Group, Ltd. | 125,383 | $3.46M |
| Renaissance Technologies LLC | 97,900 | $2.70M |
| Fred Alger Management, LLC | 92,785 | $2.56M |
| Mirabella Financial Services LLP | 25,920 | $714.0K |
| Man Group plc | 14,500 | $400.0K |
| SG Americas Securities, LLC | 14,060 | $387.0K |
| M&T Bank Corp | 10,735 | $296.0K |
| Voya Investment Management LLC | 9,650 | $266.0K |
| Invesco Ltd. | 8,263 | $228.0K |
| Evolution Wealth Advisors, LLC | 126 | $3.00K |
| Captrust Financial Advisors | 6 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 25,464 | $701.0K |